Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 19 | 2023 | 76 | 5.520 |
Why?
|
| Anti-Asthmatic Agents | 6 | 2023 | 16 | 2.140 |
Why?
|
| Telemedicine | 5 | 2023 | 45 | 1.850 |
Why?
|
| Medication Adherence | 5 | 2023 | 29 | 1.200 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2023 | 55 | 1.110 |
Why?
|
| Humans | 30 | 2023 | 12240 | 0.770 |
Why?
|
| Mobile Applications | 2 | 2020 | 20 | 0.750 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 45 | 0.740 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 48 | 0.740 |
Why?
|
| Child | 11 | 2023 | 614 | 0.670 |
Why?
|
| Monitoring, Ambulatory | 1 | 2020 | 10 | 0.640 |
Why?
|
| Adolescent | 11 | 2023 | 989 | 0.630 |
Why?
|
| Caregivers | 3 | 2019 | 95 | 0.590 |
Why?
|
| Registries | 1 | 2019 | 88 | 0.560 |
Why?
|
| Self Care | 4 | 2020 | 53 | 0.520 |
Why?
|
| Adult | 11 | 2023 | 3557 | 0.480 |
Why?
|
| Assertiveness | 1 | 2015 | 4 | 0.460 |
Why?
|
| Behavior Therapy | 1 | 2015 | 46 | 0.440 |
Why?
|
| Social Support | 2 | 2021 | 98 | 0.420 |
Why?
|
| Emergency Service, Hospital | 4 | 2017 | 191 | 0.390 |
Why?
|
| Patient Education as Topic | 3 | 2017 | 64 | 0.390 |
Why?
|
| Pandemics | 4 | 2022 | 126 | 0.380 |
Why?
|
| Patient Compliance | 1 | 2011 | 75 | 0.330 |
Why?
|
| Immunization, Passive | 4 | 2023 | 7 | 0.320 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2021 | 134 | 0.300 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 24 | 0.300 |
Why?
|
| Male | 12 | 2023 | 6815 | 0.290 |
Why?
|
| Female | 11 | 2023 | 6974 | 0.290 |
Why?
|
| Community Health Workers | 2 | 2020 | 19 | 0.260 |
Why?
|
| Minority Groups | 2 | 2015 | 40 | 0.200 |
Why?
|
| Transfusion Reaction | 1 | 2023 | 2 | 0.200 |
Why?
|
| Urticaria | 1 | 2023 | 2 | 0.200 |
Why?
|
| Patient Preference | 1 | 2023 | 20 | 0.190 |
Why?
|
| Electronic Health Records | 2 | 2020 | 31 | 0.190 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 1 | 0.180 |
Why?
|
| Adaptive Immunity | 1 | 2022 | 4 | 0.180 |
Why?
|
| Vaccination | 1 | 2022 | 9 | 0.180 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 31 | 0.180 |
Why?
|
| Hospitalization | 2 | 2022 | 158 | 0.180 |
Why?
|
| United States | 5 | 2023 | 989 | 0.170 |
Why?
|
| Endpoint Determination | 1 | 2021 | 12 | 0.170 |
Why?
|
| Electronics | 1 | 2020 | 4 | 0.160 |
Why?
|
| Feedback | 1 | 2020 | 17 | 0.160 |
Why?
|
| Lung | 1 | 2021 | 76 | 0.160 |
Why?
|
| Confidentiality | 1 | 2020 | 1 | 0.160 |
Why?
|
| Remote Sensing Technology | 1 | 2020 | 1 | 0.160 |
Why?
|
| Computer Security | 1 | 2020 | 3 | 0.160 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2020 | 9 | 0.160 |
Why?
|
| Allergy and Immunology | 1 | 2020 | 1 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 14 | 0.150 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 23 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 38 | 0.150 |
Why?
|
| Symptom Flare Up | 1 | 2019 | 1 | 0.150 |
Why?
|
| Family Relations | 1 | 2019 | 6 | 0.150 |
Why?
|
| Treatment Outcome | 3 | 2022 | 1478 | 0.150 |
Why?
|
| Quality Improvement | 2 | 2017 | 78 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 165 | 0.130 |
Why?
|
| Depression | 1 | 2019 | 229 | 0.130 |
Why?
|
| Patient Transfer | 1 | 2016 | 11 | 0.120 |
Why?
|
| Child, Preschool | 4 | 2020 | 320 | 0.120 |
Why?
|
| Middle Aged | 3 | 2022 | 4043 | 0.120 |
Why?
|
| Comparative Effectiveness Research | 1 | 2015 | 1 | 0.120 |
Why?
|
| Community Mental Health Services | 1 | 2015 | 12 | 0.120 |
Why?
|
| Smartphone | 1 | 2015 | 7 | 0.110 |
Why?
|
| MP3-Player | 1 | 2013 | 3 | 0.100 |
Why?
|
| Peer Group | 1 | 2013 | 19 | 0.100 |
Why?
|
| Housing | 1 | 2013 | 9 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2013 | 14 | 0.100 |
Why?
|
| Outpatients | 2 | 2023 | 24 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 423 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2023 | 166 | 0.090 |
Why?
|
| Animals | 1 | 2015 | 2092 | 0.080 |
Why?
|
| Quality of Life | 2 | 2023 | 261 | 0.080 |
Why?
|
| Chicago | 3 | 2017 | 453 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 295 | 0.070 |
Why?
|
| Risk Factors | 2 | 2021 | 1049 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 400 | 0.060 |
Why?
|
| Puerto Rico | 2 | 2014 | 8 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2023 | 8 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2023 | 13 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 41 | 0.050 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2023 | 3 | 0.050 |
Why?
|
| Cytokines | 1 | 2023 | 107 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 128 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2022 | 46 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 36 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2021 | 4 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 3 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 11 | 0.040 |
Why?
|
| Disease Progression | 1 | 2022 | 290 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2021 | 56 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 47 | 0.040 |
Why?
|
| Family | 1 | 2021 | 52 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 817 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 100 | 0.040 |
Why?
|
| House Calls | 1 | 2020 | 4 | 0.040 |
Why?
|
| Community Health Services | 1 | 2020 | 19 | 0.040 |
Why?
|
| Poverty | 1 | 2020 | 45 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 726 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 34 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 5 | 0.040 |
Why?
|
| Curriculum | 1 | 2020 | 74 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2019 | 20 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 55 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 78 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2019 | 35 | 0.040 |
Why?
|
| Logistic Models | 1 | 2019 | 196 | 0.040 |
Why?
|
| Young Adult | 1 | 2022 | 863 | 0.040 |
Why?
|
| Smoking | 1 | 2019 | 84 | 0.040 |
Why?
|
| Obesity | 1 | 2019 | 156 | 0.030 |
Why?
|
| Self-Management | 1 | 2017 | 4 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 1467 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 546 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 18 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 32 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2016 | 35 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 66 | 0.030 |
Why?
|
| Physicians | 1 | 2015 | 43 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 12 | 0.030 |
Why?
|
| Schools | 1 | 2014 | 16 | 0.030 |
Why?
|
| Aged | 1 | 2022 | 4000 | 0.020 |
Why?
|
| Cotinine | 1 | 2013 | 5 | 0.020 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2013 | 6 | 0.020 |
Why?
|
| Allergens | 1 | 2013 | 10 | 0.020 |
Why?
|
| Saliva | 1 | 2013 | 24 | 0.020 |
Why?
|
| Enkephalin, Methionine | 1 | 1993 | 1 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1993 | 21 | 0.020 |
Why?
|
| Urban Population | 1 | 2013 | 78 | 0.020 |
Why?
|
| Mental Health | 1 | 2013 | 47 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 153 | 0.020 |
Why?
|
| Vietnam | 1 | 1993 | 3 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 117 | 0.010 |
Why?
|
| Alcoholism | 1 | 1993 | 34 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1993 | 125 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1993 | 58 | 0.010 |
Why?
|
| Veterans | 1 | 1993 | 52 | 0.010 |
Why?
|